Please login to the form below

Not currently logged in
Email:
Password:

Siemens' healthcare unit to become standalone business

German technology firm plans to publicly list it as Siemens Healthineers

Siemens HealthineersGerman technology giant Siemens is set to spin off its healthcare unit, publicly listing Siemens Healthineers as an independent medical technology business.

Since its inception in May 2014, its health unit has brought in $15bn in sales for the company - by far its largest area - and the firm hopes the move will give it greater flexibility for further growth.

Bernd Montag, chief executive of Siemens Healthineers, said: “The public listing is a key lever for reaching our strategic goal of being the enabler for healthcare providers worldwide.

“Greater entrepreneurial freedom and agility will allow us to help shape the development of the global healthcare market and the growth strategies of successful healthcare providers.”

Siemens has yet to disclose when, or how, the healthcare business will be listed, but the company will be hoping the move will encourage investors and so provide a foundation for any future acquisitions or investments.

Siemens Healthineers is focused on supporting the industry's rapidly evolving therapeutic and molecular diagnostic market, and offers medical imaging and laboratory diagnostics, as well as management, consulting and digital services.

The unit already has deals underway with Pfizer to develop in vitro diagnostic tests to improve patient selection, treatment monitoring and dosing in clinical trials, and with ViiV Healthcare to develop diagnostics for its first-in-class HIV drug Celsentri (maraviroc).

Montag added: “We'll enable our customers to participate successfully in the trends towards consolidation, industrialisation and holistic health management with a high degree of clinical relevance, efficient workflows and financial value added.”

Article by
Rebecca Clifford

11th November 2016

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Anthill Agency

Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...

Latest intelligence

Has the pandemic opened up a future of accelerated diagnosis and better care for rare disease patients?
The challenge with rare disease is in the name – it's rare, so awareness is limited and diagnosis hindered. Could a more virtual existence change this? A Medical Affairs viewpoint...
The other side of … blood cancer
To stay motivated for the fight, some patients need to feel like active players in the treatment journey, not passengers to every decision....
COVID clinical trial
COVID-19 – a catalyst for technology adoption in clinical trials
As the COVID-19 crisis disrupts clinical trials around the globe, it is also proving to be a catalyst that may transform its approach to trials for good...

Infographics